Functional Genomics

Functional genomics is the branch of genomics that asks what genes actually do and how they work together.

6 frameworks, from 1910 to today · Genomics · Natural Sciences

still a working view ended · each leads to its entry below

Overview

Functional genomics is the branch of genomics that asks what genes actually do and how they work together1. Where classical genetics chased one trait and one gene at a time, functional genomics tries to understand the genome as a working system: which genes are switched on in which cells, what each gene product does, how genes regulate one another, and what happens when a gene is disabled1. The stakes are practical as well as intellectual. A sequenced genome is only a string of letters until someone works out which parts matter, what they build, and how they fail in disease. Functional genomics is the set of methods that turns a finished sequence into biological meaning1.

Gene-by-Gene Genetics and Its Limits

For most of the twentieth century, genetics advanced one gene at a time. The model organism was the workhorse: Drosophila melanogaster for development and inheritance, Escherichia coli and its phages for the molecular machinery of the gene, Saccharomyces cerevisiae for the cell cycle and metabolism, and later the nematode Caenorhabditis elegans and the mouse for multicellular biology. The method was the mutant hunt. Researchers treated organisms with chemicals or radiation, screened for an interesting defect, and then mapped the responsible gene by breeding2. Thomas Hunt Morgan's work on fruit-fly eye colour and wing shape in the 1910s established that genes sit on chromosomes; Barbara McClintock's cytogenetics in maize in the 1930s and 1940s linked visible chromosome behaviour to inheritance; and the phage and bacterial genetics of the 1940s and 1950s, culminating in the demonstration of DNA's structure in 1953, made the gene a physical molecule.

This approach was extraordinarily productive, but it had a structural limit. Each experiment addressed one gene, and the gene had to be found through a phenotype that someone could see or measure. Genes with subtle effects, redundant partners, or no obvious mutant phenotype were effectively invisible. By the 1980s, with sequencing arriving, the gap between the number of genes a genome contained and the number anyone could characterise one by one became the central problem of the field.

Reading the Transcriptome

The first genome-wide functional readout was the transcriptome: the complete set of RNA molecules a cell produces at a given moment. If a gene is transcribed, it is likely doing something, so measuring which RNAs are present tells you which genes are active3.

Early methods were laborious. In the 1970s and 1980s, researchers used two-dimensional gels and later Northern blots to look at a handful of transcripts at a time. The invention of the DNA microarray in the mid-1990s changed the scale. By spotting thousands of DNA probes on a glass slide, a microarray could measure the abundance of thousands of transcripts in one experiment. The classic application was the "expression cluster": in 1998, a study of yeast gene expression across the cell cycle and other conditions showed that genes with related functions tend to be switched on and off together, revealing coordinated modules of activity. Cancer studies soon used microarrays to classify tumours by their expression profiles, showing that functional genomics had clinical reach.

The limitation of microarrays was that they could only measure sequences someone had already put on the chip14. The arrival of massively parallel sequencing in the mid-2000s, and with it RNA sequencing (RNA-seq), removed that constraint: the transcripts themselves were sequenced, so any RNA present could be counted, including ones no one had predicted14. RNA-seq became the standard way to profile transcriptomes and remains so1.

Systematic Disruption: Knocking Out Genes on Purpose

Transcript profiling tells you what is switched on; it does not tell you what a gene does. To learn function, functional genomics turned to systematic disruption: disabling genes deliberately, one at a time or in bulk, and observing the consequences1.

The yeast community led the way. In the late 1990s and early 2000s, large collaborations built genome-wide collections of yeast strains in which each gene was deleted, and then screened the whole collection for growth defects, drug sensitivities, and other phenotypes. The logic was simple and powerful: if deleting a gene causes a specific problem, that gene is required for the process that fails1. In the same period, RNA interference (RNAi), discovered in C. elegans in the 1990s, gave researchers a way to knock down gene expression without permanently altering the genome, and genome-wide RNAi screens became a standard tool in worms and in cultured human cells.

The most influential systematic disruption project was in the mouse. The International Knockout Mouse Consortium, launched in the mid-2000s, set out to produce a targeted mutation in every protein-coding gene in the mouse genome, and the International Mouse Phenotyping Consortium then put those mice through standardised tests of physiology and behaviour. The point was to move from "we have a mutant" to "we have a mutant and a documented phenotype for every gene," which is the functional analogue of a reference genome.

Mapping Interactions and Regulatory Networks

Genes do not work alone, and a second strand of functional genomics mapped the wiring between them5. Two kinds of interaction matter. Genetic interactions ask whether two mutations together produce a worse (or different) effect than either alone; physical interactions ask whether two proteins bind each other16.

Yeast again provided the model. The yeast two-hybrid system, developed in the late 1980s, turned protein-protein binding into a selectable genetic signal, and by the early 2000s large-scale two-hybrid screens had produced draft maps of the yeast protein interaction network. Synthetic genetic array analysis, developed in the early 2000s, crossed a query mutation into a genome-wide collection of deletion strains to find genes whose loss is lethal only in combination with the query, revealing functional partnerships that single mutants hide. In parallel, chromatin immunoprecipitation followed by sequencing (ChIP-seq), introduced around 2007, let researchers map where specific proteins bind across the genome, turning regulatory relationships into genome-wide maps.

The conceptual payoff was the network view: genes and their products form modules, hubs, and pathways, and a gene's function is partly defined by its neighbours in that network. This is why an uncharacterised gene can be assigned a likely role because it is co-expressed with, or genetically linked to, genes of known function.

Genome-Wide Functional Annotation

As genome sequences accumulated, so did the problem of annotation: assigning function to sequences, especially the large fraction that codes for no protein. The dominant effort was the Encyclopedia of DNA Elements (ENCODE) project, launched in 2003. ENCODE set out to catalogue every functional element in the human genome—transcribed regions, protein-binding sites, chromatin states—using the full battery of functional assays. Its first major results, published in 2012, reported biochemical activity across a large majority of the genome, a claim that provoked sustained debate about what counts as "functional." The dispute was productive: it forced the field to distinguish biochemical activity from evolutionary conservation and from demonstrated biological consequence, and it shaped how later annotation projects framed their claims.

Annotation also became a community infrastructure problem. Databases such as the Gene Ontology, begun in 1998, standardised the vocabulary for describing what a gene product does, and UniProt and model-organism databases curated the evidence. Functional annotation is now a continuous, collaborative activity rather than a single project.

Single Cells and Spatial Context

The most recent transformation is resolution. Bulk transcriptome profiling averages millions of cells, hiding the differences between them7. Single-cell RNA sequencing, which became practical in the 2010s, measures transcripts in individual cells, revealing cell types, states, and trajectories that bulk methods blur. Spatially resolved methods go further, measuring gene expression while preserving where in a tissue each cell sits, so that a developing embryo or a tumour can be mapped cell by cell in its actual architecture8.

These methods descend directly from the earlier history: they are transcriptome profiling and functional annotation pushed to finer grain. They have made it possible to ask functional questions—which genes define a cell type, how a tissue organises itself, how a tumour's cells differ from one another—that bulk approaches could not address7.

Where the Field Stands

Functional genomics today is a set of interlocking approaches rather than a single method. Reference disruption collections and RNAi screens provide loss-of-function resources; RNA-seq and single-cell and spatial methods provide expression readouts; interaction mapping and network analysis provide the wiring; and annotation projects provide the shared vocabulary and reference maps. The open questions are substantial: how to move from correlation to causation at genome scale, how to interpret the function of non-coding sequence, how to connect molecular function to organism-level phenotype, and how to make these resources work across species and across human populations. The field began by asking what one gene does; it now asks what the whole working genome does, and the answers are still being assembled.

References

  1. Functional genomics (introduction, Definition and goals, SAGE, RNA sequencing, Knock-outs (gene deletions), Genetic interaction mapping), Wikipedia
  2. Forward genetics, Wikipedia
  3. Gene expression profiling (Background), Wikipedia
  4. RNA-Seq (History), Wikipedia
  5. Gene regulatory network, Wikipedia
  6. Protein–protein interaction, Wikipedia
  7. Single-cell transcriptomics (Background, introduction), Wikipedia
  8. Spatial transcriptomics, Wikipedia

The frameworks of Functional Genomics

Each framework is a way of working the field has used: when it held, and the question it answers.

  1. 1910-1995
  2. 1989-Present
  3. 1995-Present
  4. 1998-Present

    Gene knockout

    What happens when a gene is disabled?

    Fly to its tower in Nousfarer

  5. 1998-Present
  6. 2013-Present

    Single-cell transcriptomics

    Which genes define each individual cell?

    Fly to its tower in Nousfarer

How the ideas connect

Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.

Forward and Reverse GeneticsInteraction Mapping and Network Analy…Gene expression profilingGene knockoutGenome-Wide Functional AnnotationSingle-cell transcriptomics

Beyond the field

Where Functional Genomics's ideas came from in other fields, and what they led to there: the strongest 12 of 25 links.

A city in Nousfarer: a red-carpeted stair climbing terraces to a crowned tower on an acropolis, more towers round it, forest and snowy mountains beyond.
A city in Nousfarer, the game played in the browser.

Functional Genomics is a planet in Nousfarer

Its city has a tower for each of these 6 frameworks. Land, walk in, and climb one concept at a time.

Land on Functional Genomics

Related fields

Fields its ideas are linked to

More in Genomics

See where Functional Genomics sits on the Map of Human Knowledge